Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 1 to 10 of 174 resources
-
WHO policy brief on access to testing and treatment for people who inject drugs and people in prisons
The World Health Organisation (WHO) published this policy brief in April 2019 to set out the current landscape of country hepatitis policies for harm reduction and hepatitis C testing and treatment for people who inject drugs and people in prisons. It aims to capture how governments are translating the WHO Global health sector strategy on viral hepatitis 2016-2021, which the UK Government has signed up to, in national plans. It also provides a summary of the enablers and barriers to hepatitis C testing and treatment in these populations.UK, Rest of World Reports & Research, Tools & Templates, Strategy & Planning PDF -
Hepatitis C in England 2019 report
Public Health England's annual report on the UK’s progress towards eliminating hepatitis C sets out that although a lot has been achieved towards the World Health Organisation’s target of eliminating hepatitis C as a major public health threat by 2030, there is still much to do. In particular, the report calls for a 'radical change' in the health service's approach to hepatitis C among people who inject drugs.UK 09 Apr 2019 Reports & Research, Strategy & Planning PDF -
Evalution of injecting equipment providing services in NHS Tayside
The Scottish Drugs Forum and Hepatitis Scotland carried out an evaluation of the effectiveness of injecting equipment providing services, noting barriers and recommendations to Tayside NHS. The report includes information on the provision of hepatitis C testing at injecting equipment providing services.UK, Scotland Reports & Research PDF -
World Hepatitis Day 2018: Global Summary Report
This report, produced by the World Hepatitis Alliance, provides a comprehensive summary of international activity for World Hepatitis Day 2018. 144 countries, 93 governments and 53 WHO Country Offices took part across the six regions. Over 1,600 events were organised, 318,914 people attended events in their local community or country, and millions were reached online.UK, Rest of World 18 Dec 2018 Reports & Research PDF -
HCV Action and Public Health England hepatitis C roadshow in Sheffield: Presentations
On 17th October 2018, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Sheffield. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Sheffield and the wider South Yorkshire area.UK, England, Yorkshire and the Humber 12 Nov 2018 Tools & Templates PDF -
Hepatitis B and C epidemiology in selected population groups in the EU/EEA
This report details the findings of a comparative analysis of existing hepatitis B/C testing guidelines and available data on the prevalence and incidence of HBV and HCV among at-risk population groups in EU/EEA countries, to outline the key at-risk groups for hepatitis B and C in EU and EEA countires.UK, Rest of World 30 Oct 2018 Reports & Research PDF -
Addaction Hepatitis C Strategy
Substance misuse service Addaction has produced a Hepatitis C Strategy, detailing the service's five-point plan for contributing to efforts to tackle hepatitis C.UK Strategy & Planning PDF -
Good practice case study: Edinburgh Access Practice outreach service
This HCV Action good practice case study focuses on Edinburgh Access Practice's outreach service, offering testing and treatment for hepatitis C to the homeless population. In the period from March 2014 to December 2016, of the 80 referrals received, 59 patients attended (70%) and 25 started treatment, compared with typical hospital clinical attendance rates of 30-50%. From January 2017 to June 2018 use of DAAs have enabled a further 52 patients to receive treatment at the EAP over the course of just 18 months.UK, Scotland Case study PDF -
Hepatitis C in the UK 2018 Report
Public Health England's annual 'Hepatitis C in the UK' report is the key national reporting document for hepatitis C. This is the tenth such report and follows the WHO Global Health Sector Strategy on Viral Hepatitis 2016 to 2021 and the draft action plan for the health sector response to viral hepatitis in the WHO European region. The report is structured to support UK monitoring of the Global Health Sector Strategy goals and summarises the impact of UK action plans to drive down mortality from HCV and reduce the number of new infections.UK Reports & Research, Strategy & Planning PDF -
R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C
This research paper assesses the impact of (i) incentives for R&D based on providing Intellectual Property (IP) rights protection, (ii) market competition and (iii) other factors including healthcare policies on access to direct acting antivirals (DAA) for hepatitis C in Europe.UK, Rest of World Reports & Research PDF